FOXM1 and leukemia: To determine whether Foxm1 deletion delays relapse after chemotherapy in MA9 leukemia mice, we treated cohorts of MA9-Foxm1-CKO and MA9-Foxm1fl/fl recipient mice with DOXO and Ara-C.